Analyst Sticks His Neck Out, Upgrades Tempur-Pedic (TPX) to Buy Following FY12 Warning

Article Stock Quotes (1) Comments (0)

Following at least four downgrades and a whopping 49 percent decline since Tempur-Pedic (NYSE: TPX) issued a FY12 warning on Wednesday morning, one analyst is finally defending the stock. Hilliard Lyons' Joel Havard just issued a mid-day upgrade, moving the stock from Long-Term Buy to Buy. The analyst adjusted his price target from $70 to $35.

Investors are buying the recent downside Friday. About midway through the trade session, Tempur-Pedic shares are up 5.7 percent to $23.66.

For an analyst ratings summary and ratings history on Tempur-Pedic click here. For more ratings news on Tempur-Pedic click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
• UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
• UPDATE: BofA/Merrill Lynch Upgrades J. C. Penney (JCP) to Neutral

Create E-mail Alert Related Categories

Upgrades

Related Entities

Hilliard Lyons

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?